King Pharmaceuticals, Inc. (NYSE:KG)

CAPS Rating: 2 out of 5

The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.

Recs

0
Player Avatar cashman79 (38.14) Submitted: 9/15/2010 9:55:36 AM : Outperform Start Price: $9.31 KG Score: +35.42

watch

Featured Broker Partners


Advertisement